Form 4: NeuroOne Medical Technologies Director Sells Shares
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, sold a portion of his common stock holdings in two transactions on May 19 and May 20, 2025.
Summary
- Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, sold shares of common stock.
- On May 19, 2025, he sold 8,006 shares at a price of $0.6657 per share.
- On May 20, 2025, he sold 3,013 shares at a price of $0.6558 per share.
- Following these transactions, Christianson directly owns 280,472 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by a company insider. The sentiment is neutral as it simply reports a transaction.
Industry Context
Insider trading activity is always closely watched by investors as it can provide signals, though not always definitive, about a company's prospects. It is important to consider the overall context of the company's performance and industry trends when evaluating the significance of insider transactions.
Key Dates
| Date | Description |
|---|---|
| 05/19/2025 | Sale of 8,006 shares of common stock at $0.6657 per share. |
| 05/20/2025 | Sale of 3,013 shares of common stock at $0.6558 per share. |
| 05/21/2025 | Date of signature for the Form 4 filing. |
Keywords
NeuroOne Medical Technologies, NMTC, Form 4, insider trading, stock sale, Christianson, Business Development Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.